Artiva Biotherapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ARTV and other ETFs, options, and stocks.About ARTV
Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer.
CEOFred Aslan
CEOFred Aslan
Employees89
Employees89
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2019
Founded2019
Employees89
Employees89
ARTV Key Statistics
Market cap77.07M
Market cap77.07M
Price-Earnings ratio-0.95
Price-Earnings ratio-0.95
Dividend yield—
Dividend yield—
Average volume125.29K
Average volume125.29K
High today$3.30
High today$3.30
Low today$3.05
Low today$3.05
Open price$3.17
Open price$3.17
Volume125.55K
Volume125.55K
52 Week high$13.14
52 Week high$13.14
52 Week low$1.47
52 Week low$1.47
Stock Snapshot
The current Artiva Biotherapeutics(ARTV) stock price is $3.19, with a market capitalization of 77.07M. The stock trades at a price-to-earnings (P/E) ratio of -0.95.
On 2025-12-11, Artiva Biotherapeutics(ARTV) stock traded between a low of $3.05 and a high of $3.30. Shares are currently priced at $3.19, which is +4.6% above the low and -3.4% below the high.
The Artiva Biotherapeutics(ARTV)'s current trading volume is 125.55K, compared to an average daily volume of 125.29K.
In the last year, Artiva Biotherapeutics(ARTV) shares hit a 52-week high of $13.14 and a 52-week low of $1.47.
In the last year, Artiva Biotherapeutics(ARTV) shares hit a 52-week high of $13.14 and a 52-week low of $1.47.
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own ARTV. This list is generated using Robinhood data, and it’s not a recommendation.